AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 291: G518-G524, 2006. First published June 15, 2006; doi:10.1152/ajpgi.00505.2005
0193-1857/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/G518    most recent
00505.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broccardo, M.
Right arrow Articles by Improta, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broccardo, M.
Right arrow Articles by Improta, G.

INFLAMMATION/IMMUNITY/MEDIATORS

Expression of NK-1 and NK-3 tachykinin receptors in pancreatic acinar cells after acute experimental pancreatitis in rats

Maria Broccardo,1 Giorgio Linari,1 Simona Agostini,1 Giusi Amadoro,3 Francesco Carpino,2 Maria Teresa Ciotti,3 Carla Petrella,1 Vincenzo Petrozza,2 Cinzia Severini,3 and Giovanna Improta1

1Department of Human Physiology and Pharmacology, V. Erspamer, and 2Department of Experimental Medicine and Biopathology, University of Rome, La Sapienza; and 3Institute of Neurobiology and Molecular Medicine, CNR, Rome, Italy


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Activation of neurokinin (NK)-1 receptors but not of NK-3 stimulates amylase release from isolated pancreatic acini of the rat. Immunofluorescence studies show that NK-1 receptors are more strongly expressed than NK-3 receptors on pancreatic acinar cells under basal conditions. No studies have examined the expression of the two NK receptor populations in pancreatic acini during pancreatitis in rats. We therefore investigated the relationships between expression of these two tachykinin receptors and experimental acute pancreatitis induced by stimulating pancreatic amylase with caerulein (CK) in rats. Hyperstimulation of the pancreas by CK caused an increase in plasma amylase and pancreatic water content and resulted in morphological evidence of cytoplasmic vacuolization. Immunofluorescence analysis revealed a similar percentage of NK-1 receptor antibody immunoreactive acinar cells in rats with pancreatitis and in normal rat tissue but a larger percentage of NK-3 receptor immunoreactive cells in acute pancreatitis than in normal pancreas. Western blot analysis of NK-1 and NK-3 receptor protein levels after CK-induced pancreatitis showed no change in NK-1 receptors but a stronger increase in NK-3 receptor expression in pancreatic acini compared with normal rats thus confirming the immunofluorescence data. These new findings support previous evidence that substance P-mediated functions within the pancreas go beyond sensory signal transduction contributing to neurogenic inflammation, and they suggest that substance P plays a role in regulating pancreatic exocrine secretion via acinar NK-1 receptors. The significant increase in NK-3 receptors during pancreatic stimulation suggests that NK-3 receptors also intervene in the pathogenesis of mild acute pancreatitis in rats.

isolated pancreatic acini; tachykinin receptor distribution; immunofluorescence; Western blot analysis


THE NEUROPEPTIDES substance P (SP), neurokinin (NK)-A, and NK-B are primary mammalian tachykinins (TKs) involved in a wide-ranging control of peripheral and central functional activities. Each TK preferentially binds to a specific cell surface receptor subtype belonging to the superfamily of G protein-coupled receptors: SP binds to the NK-1 receptor, NK-A to the NK-2 receptor, and NK-B to the NK-3 receptor. TKs and their receptors are diffusely distributed in the mammalian gastrointestinal tract where they mediate motor, secretory, and circulatory responses (10).

To date, few reports exist on the role of the TKs in regulating exocrine pancreatic secretion. TKs acting on NK-1 and NK-2 receptors have been reported to stimulate in vitro pancreatic amylase secretion (1214, 16, 20, 33), and NK-1 and NK-2 receptors have been detected in the pancreatic acinar cells of guinea pig and mouse (6, 11, 29, 30, 32). No information is available on whether acinar cells in the pancreas of these and other animal species express the NK-3 receptor, and little is known on the effects of NK-3 receptor agonists on pancreatic exocrine secretion (7, 12, 18, 20, 33). In our recent studies, using in vitro functional (19) and immunocytochemical (4) assays, we reported that guinea pig pancreatic acinar cells contain homogeneously distributed NK-1 and NK-3 receptors that mediate a direct stimulatory action on amylase release. We also showed that in rat pancreatic acinar cells, the hitherto unidentified NK-1 receptors are widely expressed and mediate a secretagogue action on exocrine pancreas, whereas acinar NK-3 receptors are scarcely expressed and apparently do not mediate amylase release. These differences in expression and efficacy suggested that NK-1 receptors play a physiological role in pancreatic secretion in rats, whereas NK-3 receptors do not.

TKs in general, and in particular the NK-1 receptor agonist SP, mediate a variety of inflammatory processes including asthma (8, 21), inflammatory bowel disease (38), arthritis (36), and also pancreatitis (3). Information is lacking on the exact events during pancreatitis. A useful tool to define the underlying cellular and specific organ mechanisms is secretagogue-induced experimental pancreatitis. In vitro and in vivo data (34) indicate that the earliest and most important factor responsible for this experimental model of acute pancreatitis is the increase and the activation of intraacinar digestive enzymes. After this initial insult, other components (ischemia, pancreatic glutathione deficiency, oxygen free radicals, cell death, inflammatory mediators) intervene to worsen pancreatitis. Increasing evidence indicates that neurogenic proinflammatory factors, such as SP, can play important roles in determining the severity of acute pancreatitis (27), both in mice and rats. Previous data (2) show that SP levels and NK-1 receptors in pancreatic acinar cells are upregulated during experimental pancreatitis in mice. In addition, NK-1 receptor deletion or antagonism protects mice against pancreatitis (3, 9, 15). SP-induced activation of the NK-1 receptor is an important proinflammatory step also in rat acute pancreatitis. Caerulein (CK)-induced plasma extravasation, hyperamylasemia, and histological damage were blocked by antagonism of the NK-1 receptor in rats (9). Hence, CK-induced, NK-1 receptor-mediated plasma extravasation in acute pancreatitis arises from intrapancreatic release of SP. The peptide's precise etiopathogenetic mechanism nevertheless remains unclear. No study has tried to determine the possible relationship between NK-1 receptor expression in acinar cells, amylase secretion, and the severity of inflammation during pancreatitis in rats.

Despite the predominant interest in SP as a proinflammatory mediator in acute pancreatitis, current knowledge merely shows that NK-3 receptor agonists have no effect on plasma extravasation in the pancreas (9), and this receptor type, scarcely expressed on acinar cells, apparently plays no role in rat exocrine pancreatic secretion under basal conditions (4). Hence, whether NK-3 receptor agonists and NK-3 receptors are involved in this condition in rats remains unknown.

Seeking to extend the knowledge of the biological and molecular alterations linked to acute pancreatitis and the underlying regulatory events, in this study, we therefore investigated NK-1 and NK-3 receptor expression in rat pancreatic acinar cells. Using an immunofluorescence assay and Western blot analysis, we determined the expression of both receptor subtypes under normal conditions and after acute pancreatitis induced by stimulating pancreatic secretion with CK. To give evidence of pancreatic injury, we also evaluated plasma amylase levels, pancreatic water content, and morphological alterations in the pancreatic tissue.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
CK-induced experimental acute mild pancreatitis. Acute pancreatic inflammation was induced in male rats (200–250 g, Morini, RE, Italy) as previously described (5) by three intraperitoneal injections of CK (Bachem, Germany) at the dose of 10 µg/kg with a 1-h interval between injections. Normal control rats were intraperitoneally injected with a 0.9% NaCl solution. One hour after the last injection, rats were euthanized by CO2 and blood was obtained for serum amylase determinations (see Serum amylase assay). The pancreas was rapidly removed, and samples were resected for morphological evaluation and for use as isolated acini preparations. Dispersed acini were then processed for immunofluorescence, Western blot procedures and functional secretory assay.

The specific indexes evaluated to assess the degree of pancreatic inflammation included serum amylase levels, pancreatic edema, and morphological examination of pancreatic tissue.

Serum amylase assay. Amylase levels in serum were determined with the colorimetric quantitative kinetic method according to the manufacturer's instructions (Sigma). An enzyme unit was defined as the amount of enzyme that produces an increase of one absorbance unit per minute.

Pancreatic edema. To assess the development of pancreatic edema, samples of pancreas were weighed and then dried for 48–72 h at 60°C and reweighed to determine pancreatic water content. The results were calculated as (wet weight – dry weight)/wet weight and are expressed as a percentage (26).

Morphological examination. Random cross sections of the head, body, and tail of the pancreas (multiple specimens of pancreas tissue) were fixed with 4% neutral formalin and routinely paraffin embedded for histological study. Five-micrometer-thick sections were stained with hematoxylin-eosin and acid-periodic Schiff (PAS).

For transmission electron microscopy, small samples of pancreatic tissue were fixed in a 2.5% solution of purified glutaraldehyde in 0.1 M cacodylate buffer at pH 7.3, then postfixed in 1.33% osmium tetroxide. The tissues were then dehydrated in increasing concentrations of ethanol and embedded in epoxy resin (Epon 812) (37).

Semithin sections were stained with azure II methylene blue to select appropriate fields. Ultrathin sections obtained with an LKB Ultratone III were stained with uranyl acetate and lead citrate and observed under a Zeiss EM 10 electron microscope (25). Semithin section 0.5- to 1-µm thick were observed under a Zeiss photo microscope.

Rat-isolated pancreatic acini preparation. Male Wistar rats from Morini (RE, Italy), weighing 200–250 g were euthanized (70% CO2) after an overnight fast. The pancreas was harvested, and fat and lymphatic tissue was removed. Pancreatic acini were prepared by collagenase digestion as described by Peikin et al. (24). In brief, the pancreas was injected with 5 ml of digestive solution (standard buffer containing collagenase 0.2 mg/ml) and digested twice for 15 min at 37°C in a Dubnoff shaking bath (120 oscillations/min). After being hand shaken, fragments of tissue were removed and acini were dispersed by trituration with pipettes of decreasing diameter and washed twice with a standard solution containing 2% (wt/vol) albumin and 2 mM CaCl2. Acini were put into 25 ml of standard solution and centrifuged for 10 s at 150 g (at 4°C). Krebs-Ringer-HEPES buffer (pH 7.4) was used as standard solution, containing (in mM) 103 NaCl, 8 KCl, 1.2 KH2PO4, 2 glutamine, 5 glucose, 25 HEPES, 1.3 CaCl2, 0.6 MgSO4 with 1% (vol/vol) amino acid supplement, 1% (wt/vol) bovine albumin, 0.1% (wt/vol) trypsin inhibitor, and aprotinin (600 KIU/ml). Acini from the pancreas of one rat were suspended in 100 ml of standard solution and preincubated for 30 min at 37°C in a Dubnoff shaking bath. After being shaken, 10-ml aliquots of this acini suspension were rapidly distributed into vials for immunocytochemistry and Western blot procedures (see Immunocytochemistry).

Immunocytochemistry. Isolated pancreatic acini of rat were spun down on glass slides using a cytocentrifuge (Shandon) and then incubated in PBS for 1 h at 4°C with a rabbit polyclonal anti-NK-1 receptor (NB 300–101, Novus Biologicals) or anti-NK-3 receptor antibody (NB 300–102, Novus Biologicals) diluted 1:400, cross-reacting with guinea pig and rat receptors. Cells were then washed again with PBS before being incubated with a goat anti-rabbit rhodamine-conjugated secondary antibody (Sigma) for 30 min at room temperature. Cells were fixed in 4% (wt/vol) paraformaldehyde for 10 min at room temperature on immunofluorescence-labeled coverslips, then incubated with Hoechst 33258 (0.25 µg/ml) for 5 min at room temperature, then visualized with an LAICA fluorescent microscope, and counted using a x60 objective and a x10 eyepiece on an Olympus BX51 photomicroscope. Acinar cells were scored by counting 30–50 microscopic fields per coverslip in four coverslips from four to six experiments. In control experiments to assess primary antibody specificity, the primary antibodies were omitted. In these samples, no immunostaining was detected (data not shown).

Western blotting procedures. Samples of rat dispersed pancreatic acini were homogenized in ice-cold Tris-buffered saline containing 40 mM Tris·HCl (pH 7.5), 2% SDS, protease inhibitor cocktail (in mM: 0.08 aprotinin, 104 AEBSF, 1.4 E-64, 4 bestatin, 1.5 pepstatin-A, and 2 leupeptin; Sigma), 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, and 1 mM EDTA. Homogenates were centrifuged at 10,000 g for 10 min, and the supernatants were collected and stored at –70°C. Protein concentration of the homogenates was determined using the BCA protein assay kit (Pierce, Rockford, IL). For gel loading, the homogenates were heated for 4 min at 95°C in an equal volume of sample buffer (100 mM Tris, pH 6.9, 2% SDS, 2% 2-mercaptoethanol, 0.001% bromophenol blue, 20% glycerol). The samples were loaded onto 10% SDS-PAGE gels in equal protein amounts (30 mg/lane). Samples were separated by electrophoresis in Tris-glycine buffer (25 mM Tris, 250 mM glycine, 0.1% SDS) at 100 V for 120 min. Proteins were transferred overnight (12–14 h) to a polyvinylidene difluoride membrane at 30 V in transfer buffer containing 20% MeOH, 20 mM Tris, 150 mM glycine, pH 8.0. Membranes were incubated for 1 h at room temperature in blocking buffer containing 5% no-fat powdered milk in TBS-Tween (20 mM Tris, 137 mM NaCl, 0.1% Tween-20), then washed three times for 10 min each in TBS-Tween. Membranes were incubated overnight (12–14 h) with primary antibodies directed against the NK-1 receptor protein (COOH-terminus, rat NK-1 protein 393–407, Novus Biologicals) and against the NK-3 receptor protein COOH-terminus, rat NK-3 receptor protein 438–452, Novus Biologicals) in blocking-buffer at a dilution of 1:1,000 with beta-actin (1:5,000, Sigma) used as loading control. After being washed three times for 15 min each with TBS-Tween, membranes were incubated with rabbit horseradish peroxidase-conjugated secondary antibody, diluted 1:2,000 in blocking buffer for 1 h, then washed in TBS for 15 min. Peroxidase activity was detected using the Pierce SuperSignal West Femto Maximum Sensitivity Substrate kit (Pierce Chemicals, Rockford, IL) and quantified using ScanAnalysis software.

Functional secretory assay and amylase determination. Two-milliliter aliquots of the dispersed acini suspension were distributed in 25-ml flasks, incubated with the appropriate agent (SP, 10–7 M; PG-KII, 10–7 M) for 30 min at 37°C, and tested for their functional secretory activity (amylase determination). Two control flasks were prepared for each experiment. When incubation ended, the total content of the flasks was transferred into chilled tubes and centrifuged at 3,000 g for 4 min. The supernatant was collected, and acini were lysed with a buffer (pH 7.8) containing 0.01 M NaH2PO4·H2O, 0.01 M Na2HPO4·2H2O, 0.1% SDS, and 0.1% (wt/vol) albumin. Amylase activity was determined in duplicate for the media and for acini preparations using a colorimetric test (Ultimate Amylase EPS, Roche) and expressed as percentage of total cellular content. Mean percent of total amylase release from duplicate incubations for each animal was used for statistical analysis.

Drugs. SP was purchased from Peninsula Laboratories (San Carlos, CA), and PG-KII (pGlu-Pro-Asn-Glu-Phe-Val-Gly-Leu-Met-NH2) was purchased from Neosystem (Strasburg, France).

Statistics. Data are expressed as means ± SE. The significance of changes was evaluated by using Student's t-test, where necessary. For analysis of the Western blotting data, density for beta-actin control values obtained using the ScanAnalysis software was defined as 100%; experimental densities are reported as a percentage of control density.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
About 4 h after rats received three intraperitoneal injections with hyperstimulating doses of the secretagogue CK (10 µg/kg with a 1-h interval between injections), serum amylase concentrations, pancreatic edema, and ultrastructural morphology (the three indexes indicating the severity of pancreatitis) all changed. The serum amylase concentrations were about fivefold higher in CK-treated rats than in control rats (Fig. 1). CK treatment also caused a significantly larger increase in pancreatic water content (a measure of pancreatic edema) in treated rats than in normal control rats (P < 0.05; Fig. 1). In CK-hyperstimulated rats, light microscopy disclosed no evident pancreatic lesions (data not reported). Conversely, transmission electron microscopy disclosed marked ultrastructural alterations of the pancreatic tissue (Fig. 2). The acinar cells showed changes in the plasma membrane with a reduction in the number of microvilli and density of intracytoplasmic zymogene granule, formation of cytoplasmic vacuoles, dilatation of the rough endoplasmic reticulum cisternae, and mitochondrial damage. Acinar-cell nuclei had minimal lesions and showed prominent nucleoli.


Figure 1
View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1. The effect of caerulein (CK) injected 3 hourly (10 µg·kg–1·h–1 ip) on serum amylase concentrations and pancreatic water content in rats. Results are the means ± SE from 7 separate experiments. *P < 0.05 and **P < 0.001 vs. controls (no pancreatitis).

 

Figure 2
View larger version (55K):
[in this window]
[in a new window]
 
Fig. 2. Ultrastructural sections of pancreatic acinar cells from control rats (A) and after CK-induced pancreatitis (B). N, nucleus; Z, zimogen; V, vacuoles; ER, endoplasmic reticulum; M, mitochondria; NI, prominent nucleoli. Arrow is for diminished luminal microvilli.

 
In samples of dispersed pancreatic acinar cells prepared from normal control rats, immunofluorescent staining of NK-1 and NK-3 receptors showed a typical punctuate membrane localization, but they differed markedly in density (Fig. 3, A and C). Cell counts indicated a larger number of acinar NK-1 immunoreactive cells than NK-3 immunoreactive cells (51 ± 6 vs. 8 ± 2%; Table 1). Photomicrographs of pancreatic acinar cells after CK-induced acute pancreatitis disclosed a similar staining density for NK-1 receptors and a larger density of NK-3 receptors in stimulated than in control unstimulated pancreatic samples (Fig. 3, B and D). Cell counts revealed an equal percentage of acinar NK-1 immunoreactive cells after CK-induced pancreatitis and in normal pancreas (50% ± 8 vs. 51% ± 6; Table 1) but a larger percentage of NK-3 immunoreactive cells in CK-induced pancreatitis than in normal pancreas (85 ± 3 vs. 8.0 ± 2; Table 1). The lack of detectable staining when the secondary antibodies were used alone confirmed the specificity of the antibodies used in this study.


Figure 3
View larger version (98K):
[in this window]
[in a new window]
 
Fig. 3. Neurokinin (NK)-1 receptor (NK-1R) and NK-3 receptor (NK-3R) immunofluorescent staining in pancreatic acinar cells in control rats (no pancreatitis; A and C) and after CK-induced pancreatitis (B and D).

 

View this table:
[in this window]
[in a new window]
 
Table 1. Immunofluorescent cell counts

 
Western blotting analysis of NK-1 and NK-3 receptor protein levels (Fig. 4A) showed no change in NK-1 receptor protein expression in pancreatic acini after CK pancreatitis compared with control unstimulated acini. In contrast, CK-hyperstimulated pancreatic acini exhibited a more intense signal for NK-3 receptor protein expression than did normal acini. The densitometric analysis demonstrated about a threefold larger increase in NK-3 receptor protein levels in pancreatic acini hyperstimulated with CK than in unstimulated acini (Fig. 4B). Equal amounts of proteins were loaded for each sample, as demonstrated by the comparable density levels for beta-actin, used as internal control, confirming that the differences in immunoreactivity observed in the different bands did not depend on the different amounts of proteins loaded.


Figure 4
View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4. Lane 1, top: representative Western blot analysis of NK-1 and NK-3 receptor proteins (50 kDa) from control pancreatic acini; bottom: levels of internal control protein beta-actin (42 kDa). Lane 2, top: levels of NK-1 receptor and NK-3 receptor; bottom: beta-actin protein in CK-induced pancreatitis. Quantitation of the density of the Western blotting bands. The levels of NK-1 receptor and NK-3 receptor proteins in control rats and in CK-induced pancreatitis are expressed as percentages of the density in beta-actin controls.

 
Functional secretory assays indicated that the basal amylase secretion by pancreatic acinar cells after acute experimental pancreatitis in rats was significantly higher than that obtained in pancreatic acinar cells under normal conditions (16.5 ± 3.1 vs. 6.5 ± 0.5 ). The NK-1 receptor agonist SP (10–7 M), when added to dispersed pancreatic acini, induced a quantitatively comparable increase of amylase release under normal conditions (12 ± 1.5 vs. 6.5 ± 0.5) and after CK-induced pancreatitis (21.9 ± 3.5 vs. 16.5 ± 3.1). In contrast, the NK-3 receptor agonist PG-KII (10–7 M), which under normal conditions left basal amylase release unchanged ( 6.3 ± 1.2 vs. 6.5 ± 0.5), significantly increased enzyme secretion after CK-induced pancreatitis (30.7 ± 2.9 vs. 16.5 ± 3.1; Table 2).


View this table:
[in this window]
[in a new window]
 
Table 2. Effects of SP and PG-KII on amylase release from rat dispersed pancreatic acini under normal condition and after pancreatitis

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
To our knowledge, this is the first study reporting the expression of NK-1 and NK-3 receptors in pancreatic acinar cells after acute experimental pancreatitis in rats. Whereas CK-induced pancreatitis left NK-1 receptor expression pancreatic acini apparently unchanged compared with normal pancreas, it caused NK-3 receptor overexpression. In this secretagogue-induced model of acute pancreatitis, hyperamylasemia, increased pancreatic water content, and ultrastructural alterations in the pancreatic tissue provided clear evidence of mild pancreatic injury.

SP is found in the majority of fibers innervating the pancreas. The NK-1 receptor agonist SP has been considered the neurogenic factor playing an important role in the inflammatory cascade in experimental pancreatitis in rats (23). Studies using immunohistochemistry and Western blotting analysis show NK-1 receptor upregulation in pancreatic tissues of rats (35) and also in humans (31) during pancreatitis. CK hyperstimulation in mice causes biochemical and histological evidence of acute pancreatitis via capsaicin VR1 receptors on primary sensory neurons, which release the endogenous SP responsible for the inflammatory cascade (23). Similarly, during experimental pancreatitis in mice, pancreatic levels of SP undergo several-fold upregulation after three hourly injections of CK, and NK-1 receptor antagonists protect against acute pancreatitis (17).

Notwithstanding this knowledge, precisely how SP contributes to the severity of pancreatitis is not clear. Recent observations that the expression of NK-1 receptors is markedly increased on acinar cells in samples prepared from mice with pancreatitis induced by 12 hourly injections of CK (2) suggest that SP may exert its proinflammatory effect directly on the acinar cells (17). Hence, CK-stimulated amylase release could be considered the earliest and sensory neuron-independent event in the induction of CK pancreatitis in mice. In line with this hypothesis, our previous results in rats (19) have demonstrated that under normal conditions, by directly activating acinar NK-1 receptors, SP stimulates pancreatic secretion, thus indicating that also in rats, SP-mediated functions within the pancreas could go beyond sensory signals of neurogenic inflammation alone.

Our new findings on the expression of NK-1 receptors on the pancreatic acini during CK-induced pancreatitis in rats showed that the already dense distribution of NK-1 receptors under normal conditions remains quantitatively unchanged after CK pancreatitis. Furthermore, functional data, showing that SP evoked a similar increase in amylase release under normal and pathological conditions, give a further confirm that after pancreatitis in rats the NK-1 receptors do not change their expression. This finding differs substantially from what has been previously reported in mice acinar cells expressing an increased number of NK-1 receptors after pancreatitis (2). Because our study in rats investigated mild acute pancreatitis, whereas others investigating mice studied severe pancreatitis, the severity of pancreatitis could explain the different NK-1 receptor expression obtained in rats and mice. However, our preliminary but not reported immunocytochemistry and Western blot results, indicating that rat acinar cells express the same number of NK-1 receptors after mild and severe pancreatitis, remove this possibility. Even if further investigation are required, beside the different severity of pancreatitis, the only alternative we can put forward is a species difference.

A further distinctive finding in this study is that the TK receptor subtype NK-3, which has a very low density in rat pancreatic acinar cells under basal conditions, became upregulated after secretagogue-induced pancreatitis. In addition, NK-3 receptor agonists, which are completely inactive on exocrine pancreatic secretion under normal conditions, significantly stimulate amylase secretion in rat acinar cells after pancreatitis. Overall, these findings to date indicate that NK-3 receptors, which apparently have no physiological role in pancreatic secretion in rats, under CK stimulation become activated, alter cell function, and probably intervene in mediating acute pancreatitis.

Differences in the function and expression of the two TK receptor classes depend closely on the regulatory processes they trigger. NK-1 and NK-3 receptors exhibit marked differences in the rate of resensitization and in their ability to colocalize with isoforms of beta-arrestins (determined by domains in intracellular loop 3 and the COOH tail), and these differences could have important functional implications. CK-induced SP release activates subsequent NK-1 receptor endocytosis in acinar cells (22). After activation, NK-1 receptors interact with beta-arrestins 1 and 2 with high affinity, internalize rapidly, but are slowly resensitized (28). The NK-1 receptor desensitization in the continued presence of agonist presumably occurs via mechanisms that implicate G protein-coupled receptor kinase and beta-arrestins. Biochemical and electrophysiological studies on cells expressing NK-1 receptors indicate that NK-1 receptor signaling diminishes within seconds after agonist exposure (1). Conversely, NK-3 receptors transiently interact with beta-arrestin (preferentially beta-arrestin 2), are largely excluded from endosomes, and rapidly resensitized (28). In pancreatic acinar cells coexpressing NK-1 and NK-3 receptors such as enteric neurons and endothelial cells, the activation of the NK-1 receptor, by sequestering beta-arrestins and NK-1 receptors in endosomes, contributes to desensitization by depleting NK-1 receptors from the cell surface and by impeding endocytosis of NK-3 receptors causes their retention on the cell surface. Such regulation could allow the NK-3 receptor to become the major receptor responding to SP at a time when NK-1 receptors are desensitized and internalized. Rapid and increased resensitization of the NK-3 receptor would permit cells to respond quickly to SP stimulation. Hence NK-1 and NK-3 receptors might both be involved in the stimulatory secretory pathway participating in the pathogenesis of acute pancreatitis in rats.

In conclusion, this study suggests that SP could mediate the inflammatory response to acute pancreatitis in rats directly by activating TK acinar cell receptors. Whether the interaction of SP with pancreatic acinar cells and the resulting increase in enzyme release or the production of other inflammatory mediators contribute to its proinflammatory role in experimental pancreatitis in rats requires elucidation.

An extended knowledge of the biological and molecular alterations linked to acute pancreatitis and the underlying regulatory events will open the way for new therapies for this life-threatening condition. Once the responsible receptors are identified, selective antagonists able to block these receptors could be useful therapeutic remedies.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported by grants from the Italian Ministry of University and Scientific and Technological Research.


    ACKNOWLEDGMENTS
 
The authors thank C. Munari for expert technical assistance in performing the experiments.


    FOOTNOTES
 

Address for reprint requests and other correspondence: G. Improta, Dipartimento di Fisiologia Umana e Farmacologia "V. Erspamer" Università di Roma "La Sapienza"- P.le A. Moro 5–00185 Roma, Italia (e-mail: giovanna.improta{at}uniroma1.it)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Barak LS, Warabi K, Feng X, Caron MG, and Kwatra MM. Real-time visualization of the cellular redistribution of G protein-coupled receptor kinase 2 and beta-arrestin 2 during homologous desensitization of the substance P receptor. J Biol Chem 274: 7565–7569, 1999.[Abstract/Free Full Text]
  2. Bhatia M, Saluja AK, Hofbauer B, Frossard JL, Lee HS, Castagliuolo I, Wang CC, Gerard N, Pothoulakis C, and Steer ML. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci USA 95: 4760–4765, 1998.[Abstract/Free Full Text]
  3. Bathia M, Slavin J, Cao Y, Basbaum AI, and Neoptolemos JP. Preprotachykinin-A gene deletion protects mice against acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 284: G830–G836, 2003.[Abstract/Free Full Text]
  4. Broccardo M, Ciotti MT, Linari G, Agostini S, Petrella C, Amadoro G, Severini C, and Improta G. Immunocytochemical distribution of NK-1 and NK-3 tachykinin receptors in isolated pancreatic acini of guinea pigs and rats. Peptides 26: 2351–2354, 2005.[CrossRef][ISI][Medline]
  5. Clemons AP, Holstein DM, Galli A, and Saunders C. Cerulein-induced acute pancreatitis in the rat is significantly ameliorated by treatment with MEK1/2 inhibitors U0126 and PD98059. Pancreas 25: 251–259, 2002.[CrossRef][ISI][Medline]
  6. De Giorgio R, Sternini C, Anderson K, Brecha NC, and Go VLW. Tissue distribution and innervation pattern of peptide immunoreactivities in the rat pancreas. Peptides 13: 91–98, 1992.[CrossRef][ISI][Medline]
  7. Doi R, Inoue K, Kogire M, Sumi S, Takaori K, Yun M, Yajima H, and Tobe T. Effects of synthetic Kassinin on splanchnic circulation and exocrine pancreas in dogs. Peptides 9: 1055–1058, 1988.[CrossRef][ISI][Medline]
  8. Figini M, Emanueli C, Bertrand C, Javdan P, and Geppetti P. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor. Br J Pharmacol 117: 1270–1276, 1996.[ISI][Medline]
  9. Grady EF, Yoshimi SK, Maa J, Valeroso D, Vartanian RK, Rahim S, Kim EH, Gerard C, Gerard N, Bunnett NW, and Kirkwood KS. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol 130: 505–512, 2000.[CrossRef][ISI][Medline]
  10. Holzer P and Holzer-Petsche U. Tachykinin receptors in the gut: physiological and pathological implications. Curr Opin Pharmacology 1: 583–590, 2001.
  11. Ihara H and Nakanishi S. Selective inhibition of expression of the substance P receptor mRNA in pancreatic acinar AR42J cells by glucocorticoids. J Biol Chem 265: 22441–22445, 1990.[Abstract/Free Full Text]
  12. Jensen RT and Gardner JD. Interaction of physalaemin, substance P and eledoisin with specific receptors on pancreatic acinar cells. Proc Natl Acad Sci USA 76: 5679–5683, 1979.[Abstract/Free Full Text]
  13. Jensen RT, Jones SW, Lu YA, Folkers K, and Gardner JD. Interaction of substance P receptors on dispersed pancreatic acini. Biochim Biophys Acta 804: 181–191, 1984.[Medline]
  14. Katoh K, Murai K, and Nonoyama T. Effects of substance P on fluid and amylase secretion in exocrine pancreas of rat and mouse. Res Vet Sci 36: 147–152, 1984.[ISI][Medline]
  15. Kirkwood KS, Kim EH, He XD, Calaustro EQ, Domush C, Yoshimi SK, Grady EF, Maa J, Bunnett NW, and Debas HT. Substance P inhibits pancreatic exocrine secretion via a neural mechanism. Am J Physiol Gastrointest Liver Physiol 277: G314–G320, 1999.[Abstract/Free Full Text]
  16. Konturek SJ, Jaworek J, Tasler J, Cieszkowski M, and Pawlik W. Effect of substance P and its C-terminal hexapeptide on gastric and pancreatic secretion in the dog. Am J Physiol Gastrointest Liver Physiol 240: G74–G81, 1981.
  17. Lau HY, Wong FL, and Bhatia M. A key role of neurokinin 1 receptors in acute pancreatitis and associated lung injury. Biochem Biophys Res Commun 327: 509–515, 2005.[CrossRef][ISI][Medline]
  18. Linari G, Broccardo M, Nucerito V, and Improta G. Selective tachykinin NK3-receptor agonists stimulate in vitro exocrine pancreatic secretion in the guinea pig. Peptides 23: 947–953, 2002.[CrossRef][ISI][Medline]
  19. Linari G, Improta G, Agostini S, Andreassi A, and Broccardo M. Stimulatory effect of PG-KII, an NK3 tachykinin receptor agonist, on isolated pancreatic acini: species-related differences. Peptides 25: 45–51, 2004.[CrossRef][ISI][Medline]
  20. May RJ, Conlon TP, Erspamer V, and Gardner JD. Actions of peptides isolated from amphibian skin on pancreatic acinar cells. Am J Physiol Endocrinol Metab 235: E112–E118, 1978.[Abstract/Free Full Text]
  21. Naline E, Molimard M, Regoli D, Emonds-Alt X, Bellamy JF, and Advenier C. Evidence for functional tachykinin NK1 receptors on human isolated small bronchi. Am J Physiol Lung Cell Mol Physiol 271: L763–L767, 1996.[Abstract/Free Full Text]
  22. Nathan JD, Patel AA, McVey DC, Thomas JE, Prpic V, Vigna SR, and Liddle RA. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 281: G1322–G1328, 2001.[Abstract/Free Full Text]
  23. Nathan JD, Peng RY, Wang Y, McVey DC, Vigna SR, and Liddle RA. Primary sensory neurons: a common final pathway for inflammation in experimental pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 283: G938–G946, 2002.[Abstract/Free Full Text]
  24. Peikin SR, Rotman AJ, Baztri S, and Gardner JD. Kinetics of amylase release by dispersed acini prepared from guinea pig pancreas. Am J Physiol Endocrinol Metab 235: E743–E749, 1978.[Abstract/Free Full Text]
  25. Reynold ES. The use of lead citrate at high pH and elective opaque stain in electron microscopy. J Cell Biol 17: 208–212, 1963.[Free Full Text]
  26. Saluja AK, Saluja M, Printz H, Zavertnik A, Sengupta A, and Steer ML. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc Natl Acad Sci USA 86: 8968–8971, 1989.[Abstract/Free Full Text]
  27. Saluja AK and Steer ML. Pathophysiology of pancreatitis. Role of cytokines and other mediators of inflammation. Digestion 60: 27–33, 1999.[Medline]
  28. Schmidlin F, Dery O, Bunnett NW, and Grady EF. Heterologous regulation of trafficking and signaling of G protein-coupled receptors:beta-arrestin-dependent interactions between neurokinin receptors. Proc Natl Acad Sci USA 99: 3324–3329, 2002.[Abstract/Free Full Text]
  29. Schmidt P, Steen SP, Torben NR, Bersani M, and Jens JH. Substance P and neurokinin A are codistributed and colocalized in the porcine gastrointestinal tract. Peptides 12: 963–973, 1991.[CrossRef][ISI][Medline]
  30. Sharkey KA, Williams RG, and Dockray GJ. Sensory substance P innervation of the stomach and pancreas. Demonstration of capsaicin-sensitive sensory neurons in the rat by combined immunohistochemistry and retrograde tracing. Gastroenterology 87: 914–921, 1984.[ISI][Medline]
  31. Shrikhande SV, Friess H, di Mola FF, Tempia-Caliera A, Conejo Garcia JR, Zhu Z, Zimmermann A, and Buchler MW. NK-1 receptor gene expression is related to pain in chronic pancreatitis. Pain 91: 209–217, 2001.[CrossRef][ISI][Medline]
  32. Sjodin L, Brodin E, and Srivastava G. Interaction of substance P with dispersed pancreatic acinar cells from the guinea pig. Relationships between structure, binding and biological activity. Acta Physiol Scand 120: 21–26, 1984.[ISI][Medline]
  33. Sjodin L and Gylfe E. A selective and potent antagonist of substance P receptors on pancreatic acinar cells. Biochem Int 27: 145–153, 1992.[ISI][Medline]
  34. Steer ML. Frank Brooks memorial Lecture: The early intraacinar cell events which occur during acute pancreatitis. Pancreas 17: 31–37, 1998.[CrossRef][ISI][Medline]
  35. Vera-Portocarrero LP and Westlund KN. Attenuation of nociception in a model of acute pancreatitis by an NK-1 antagonist. Pharmacol Biochem Behav 77: 631–640, 2004.[CrossRef][ISI][Medline]
  36. Walsh DA, Mapp PI, Wharton J, Rutherford RA, Kidd BL, Revell PA, Blake DR, and Polak JM. Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis. Ann Rheum Dis 51: 313–317, 1992.[Abstract/Free Full Text]
  37. Watson ML. Staining of tissue section for electron microscopy with heavy metal. Biophys J 4: 275–482, 1958.
  38. Yamamoto H, Morise K, Kusugami K, Furusawa A, Konagaya T, Nishio Y, Kaneko H, Uchida K, Nagai H, Mitsuma T, and Nagura H. Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease. J Gastroenterol 31: 525–532, 1996.[CrossRef][ISI][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/G518    most recent
00505.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broccardo, M.
Right arrow Articles by Improta, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broccardo, M.
Right arrow Articles by Improta, G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.